Results 31 to 40 of about 378,540 (249)

A Video-Based Augmented Reality System for Human-in-the-Loop Muscle Strength Assessment of Juvenile Dermatomyositis

open access: yesIEEE Transactions on Visualization and Computer Graphics, 2023
As the most common idiopathic inflammatory myopathy in children, juvenile dermatomyositis (JDM) is characterized by skin rashes and muscle weakness.
Kanglei Zhou   +9 more
semanticscholar   +1 more source

CORRELATIONS BETWEEN NAILFOLD CAPILLAROSCOPY FINDINGS AND DISTINCT CLINICAL FORMS OF JUVENILE DERMATOMYOSITIS [PDF]

open access: yesRomanian Journal of Rheumatology, 2019
Juvenile dermatomyositis is the most common idiopathic inflammatory myopathy in childhood. Nailfold capillaroscopy plays an important role in its assessment, being useful for diagnosis and follow-up.
Sigrid Covaci   +2 more
doaj   +1 more source

Role of mitochondria in the myopathy of juvenile dermatomyositis and implications for skeletal muscle calcinosis

open access: yesJournal of Autoimmunity, 2023
Objectives: To elucidate mechanisms contributing to skeletal muscle calcinosis in patients with juvenile dermatomyositis. Methods: A well-characterized cohorts of JDM (n = 68), disease controls (polymyositis, n = 7; juvenile SLE, n = 10, and RNP ...
Bhargavi Duvvuri   +11 more
semanticscholar   +1 more source

Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China

open access: yesArthritis Research & Therapy, 2023
Objectives Juvenile dermatomyositis (JDM) is a chronic autoimmune disease. Some patients remain in an active state even though they were administrated with a combination of corticosteroid and methotrexate.
Junmei Zhang   +13 more
semanticscholar   +1 more source

Nailfold capillary density in 140 untreated children with juvenile dermatomyositis: an indicator of disease activity

open access: yesPediatric Rheumatology Online Journal, 2023
Background We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End Row Loop (ERL) loss with disease damage in children with newly ...
L. Pachman   +4 more
semanticscholar   +1 more source

Improvement in Disease Activity in Refractory Juvenile Dermatomyositis Following Abatacept Therapy

open access: yesArthritis & Rheumatology, 2023
This open‐label, 24‐week study was conducted to evaluate the safety and efficacy of abatacept in patients with refractory juvenile dermatomyositis (DM).
R. Curiel   +10 more
semanticscholar   +1 more source

Juvenile dermatomyositis

open access: yesUgeskrift for Læger, 2023
Juvenile dermatomyositis (JDM) is a rare condition, which causes inflammation in children’s skin and musculoskeletal systems. Symptoms include characteristic skin rashes on the face and extremities, muscle pain and weakness. This is a case report of a ten-year-old boy initially suspected of having lupus erythematosus. He was later diagnosed with JDM by
Vigand Svendsen, Sebastian   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy